canada-pricing

Canada Approves First Generic Semaglutide: Prices and Timeline

Health Canada authorized the first generic injectable semaglutide on April 28, 2026, making Canada the first G7 nation to approve it. This approval promises lower prices, with generics potentially dropping to $112 per pen as more enter the market, compared to the brand price of $320. A study shows that at $100 per month, nearly six times more Canadians would consider these treatments versus $400 per month.